max dose of retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide vs tirzepatide dosage chart:

These benefits were highlighted in 2019 when the Lancet published a meta-analysis of seven clinical trials showing that these treatments reduced hospital admission by 9%, all-cause mortality by 12% and deaths associated with kidney disease by 17% (Wilding et al., 2021)

119 Prandial injections of GLP-1 given to obese but otherwise healthy volunteers for five days resulted in a mean body weight loss of 0.55 kg

Tirzepatide works because it directly modulates appetite signaling and insulin dynamics through receptor binding that has been validated in multiple Phase 3 randomised controlled trials

Gut Zoomer The Gut Zoomer panel is a great add-on to the OAT test

A randomized, controlled trial of 3.0 mg of liraglutide in weight management